The deal priced below last closing price of $1.89. Titan Partners is acting as sole book running manager for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
- Gain Therapeutics Announces Proposed Public Offering
- Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
- Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
- Gain Therapeutics sees cash runway into 2025